Table II. Characteristics of populations based on the CRP level
CRP < 1 mg/l (n = 25)CRP = 1–3 mg/l (n = 35)CRP > 3 mg/l (n = 31)p Value
NETs (OD)0.079 ± 0.0100.160 ± 0.0220.158 ± 0.026p ≤ 0.015
CRP (mg/l)0.65 ± 0.061.94 ± 0.107.18 ± 0.61p ≤ 0.016
MPO (ng/ml)292.1 ± 33.0311.0 ± 32411.8 ± 48.3p = 0.034
IL-6 (pg/ml)01.74 ± 0.514.77 ± 0.57p = 0.0001
ST2 (ng/ml)22.0 ± 1.831.1 ± 4.858.0 ± 15.6p = 0.045
Creatinine (mmol/l)90.0 ± 3100.4 ± 6.6126.1 ± 10p = 0.002
Fasting glucose (mmol/l)6.34 ± 0.537.12 ± 0.437.77 ± 0.47p = 0.036
Total cholesterol (mmol/l)4.49 ± 0.283.85 ± 0.173.26 ± 0.19p = 0.001
LDL (mmol/l)2.66 ± 0.272.11 ± 0.161.65 ± 0.14p = 0.001
Triglycerides (mmol/l)1.80 ± 0.151.81 ± 0.171.58 ± 0.15
Statins (%)11 (44)16 (45.7)21 (67.7)
Comorbidity n (%)4 (16)16 (45.7)16 (51.6)p = 0.005
Age (y)60.2 ± 1.665.6 ± 265.6 ± 2
Sex: male n (%)21 (84)24 (68.6)23 (74.2)
HC n (%)15 (60)9 (25.7)1 (3.2)
T2DM n (%)3 (12)12 (34.3)6 (19.4)
HF n (%)3 (12)8 (22.9)8 (25.8)
HF with T2DM n (%)4 (16)6 (17.1)16 (51.6)
  • Values are mean ± SE or percentage.

  • ST2, cardiac damage biomarker.